β‑catenin regulates effects of miR‑24 on the viability and autophagy of glioma cells

Chen,Hanchun; Lu,Qiong; Chen,Chao; Di,Yunhai; Li,Ya'nan; Min,Weijie; Yu,Zhengquan; Dai,Dongwei

doi:10.3892/etm.2019.7680

β‑catenin regulates effects of miR‑24 on the viability and autophagy of glioma cells

Authors:
- Hanchun Chen
- Qiong Lu
- Chao Chen
- Yunhai Di
- Ya'nan Li
- Weijie Min
- Zhengquan Yu
- Dongwei Dai
View Affiliations

Affiliations: Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu 215021, P.R. China, Department of Laboratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China, Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China, Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
Published online on: June 18, 2019 https://doi.org/10.3892/etm.2019.7680
Pages: 1285-1290

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mutations of the β‑catenin gene are common in various cancer types. MicroRNA (miR)‑24 suppresses gene expression during the cell cycle. However, the effects of miR‑24 on the cell viability and autophagy of glioma cells, and how these biological processes are regulated by β‑catenin are largely unclear. The current study aimed to investigate the role of β‑catenin in regulating the effects of miR‑24 on the cell viability and autophagy of glioma cells. The expression levels of microtubule‑associated proteins 1A/1B light chain 3B (LC3B) and Beclin1 were detected by immunohistochemistry and western blotting. Glioma C6 cells were transfected with miR‑24 mimics, miR‑24 inhibitors and negative control miRNAs. C6 cells transfected with miR‑24 mimics or negative control miRNAs were treated with the β‑catenin inhibitor, XAV‑939. An MTT assay was utilized to evaluate the viability of C6 cells. The expression of miR‑24 and mRNA expression of autophagy related 4a cysteine peptidase (ATG4A) were detected by quantitative polymerase chain reaction analysis. The protein expression of LC3B and Beclin1 decreased significantly in glioma tissue and glioma C6 cells compared with normal brain tissue. Compared with the negative control group, C6 cells transfected with miR‑24 mimics exhibited significantly higher cell viability at 24 and 48 h, and those transfected with miR‑24 inhibitors exhibited significantly lower cell viability at 48 h. XAV‑939 decreased the stimulatory effects of miR‑24 mimics on the viability of C6 cells. The expression of miR‑24 significantly decreased and ATG4A mRNA significantly increased in C6 cells transfected with XAV‑939 compared with those transfected with the negative control miRNA. XAV‑939 attenuated the miR‑24‑induced decrease of the protein expression of LC3B and Beclin1, and decreased the stimulatory effects of miR‑24 mimics on cell viability. In addition, XAV‑939 attenuated the miR‑24‑induced decrease of autophagy marker expression by attenuating miR‑24 expression and increasing ATG4A mRNA expression in glioma C6 cells. To the best of our knowledge, the present study is the first to demonstrate whether β‑catenin regulates the intracellular effects of miR‑24 on the viability and autophagy of glioma cells. The results also provide some mechanistic basis to the pharmaceutical targeting of WNT signaling in high grade glial tumors.

View Figures

View References

1	Goodenberger ML and Jenkins RB: Genetics of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
2	Bleeker FE, Molenaar RJ and Leenstra S: Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 108:11–27. 2012. View Article : Google Scholar : PubMed/NCBI
3	Weis WI and Nelson WJ: Re-solving the cadherin-catenin-actin conundrum. J Biol Chem. 281:35593–35597. 2006. View Article : Google Scholar : PubMed/NCBI
4	Saldanha G, Ghura V, Potter L and Fletcher A: Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol. 151:157–164. 2004. View Article : Google Scholar : PubMed/NCBI
5	MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
6	Tao H, Guo L, Chen L, Qiao G, Meng X, Xu B and Ye W: MSX1 inhibits cell migration and invasion through regulating the Wnt/β-catenin pathway in glioblastoma. Tumour Biol. 37:1097–1104. 2016. View Article : Google Scholar : PubMed/NCBI
7	Singh T and Katiyar SK: Green tea polyphenol, (−)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling. Toxicol Appl Pharmacol. 273:418–424. 2013. View Article : Google Scholar : PubMed/NCBI
8	Dong HJ, Jang GB, Lee HY, Park SR, Kim JY, Nam JS and Hong IS: The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells. Sci Rep. 6:229662016. View Article : Google Scholar : PubMed/NCBI
9	Wei A, Fan B, Zhao Y, Zhang H, Wang L, Yu X, Yuan Q, Yang D and Wang S: ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway. Oncotarget. 7:65374–65388. 2016. View Article : Google Scholar : PubMed/NCBI
10	Chen J, Rajasekaran M, Xia H, Zhang X, Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BK, Ooi LL, et al: The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Gut. 65:1522–1534. 2016. View Article : Google Scholar : PubMed/NCBI
11	Lal A, Kim HH, Abdelmohsen K, Kuwano Y, Pullmann R Jr, Srikantan S, Subrahmanyam R, Martindale JL, Yang X, Ahmed F, et al: p16(INK4a) translation suppressed by miR-24. PLoS One. 3:e18642008. View Article : Google Scholar : PubMed/NCBI
12	Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O, et al: miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to ‘seedless’ 3′UTR microRNA recognition elements. Mol Cell. 35:610–625. 2009. View Article : Google Scholar : PubMed/NCBI
13	Amelio I, Lena AM, Viticchiè G, Shalom-Feuerstein R, Terrinoni A, Dinsdale D, Russo G, Fortunato C, Bonanno E, Spagnoli LG, et al: miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration. J Cell Biol. 199:347–363. 2012. View Article : Google Scholar : PubMed/NCBI
14	Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD and Chen YG: MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood. 111:588–595. 2008. View Article : Google Scholar : PubMed/NCBI
15	Yin Y, Zhong J, Li SW, Li JZ, Zhou M, Chen Y, Sang Y and Liu L: TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer. Oncotarget. 7:86755–86765. 2016. View Article : Google Scholar : PubMed/NCBI
16	Pan B, Chen Y, Song H, Xu Y, Wang R and Chen L: Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A. Oncotarget. 6:317–331. 2015. View Article : Google Scholar : PubMed/NCBI
17	Cherra SJ III, Kulich SM, Uechi G, Balasubramani M, Mountzouris J, Day BW and Chu CT: Regulation of the autophagy protein LC3 by phosphorylation. J Cell Biol. 190:533–539. 2010. View Article : Google Scholar : PubMed/NCBI
18	Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, et al: Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 461:614–620. 2009. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Cui Y, Ma W, Lei F, Li Q, Su Y, Lin X, Lin C, Zhang X, Ye L, Wu S, et al: Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling. J Pathol. 239:297–308. 2016. View Article : Google Scholar : PubMed/NCBI
21	Wu S, Wang S, Zheng S, Verhaak R, Koul D and Yung WK: MSK1-mediated β-catenin phosphorylation confers resistance to PI3K/mTOR inhibitors in glioblastoma. Mol Cancer Ther. 15:1656–1668. 2016. View Article : Google Scholar : PubMed/NCBI
22	Yan Z, Wang J, Wang C, Jiao Y, Qi W and Che S: miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth. FEBS Lett. 588:3038–3046. 2014. View Article : Google Scholar : PubMed/NCBI
23	Guo M, Zhang X, Wang G, Sun J, Jiang Z, Khadarian K, Yu S, Zhao Y, Xie C, Zhang K, et al: miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1. Cancer Lett. 360:76–86. 2015. View Article : Google Scholar : PubMed/NCBI
24	Liu Y, Cui M, Lu Z, Yang Q and Dong Q: Tissue kallikrein promotes survival and β-catenin degradation in SH-SY5Y cells under nutrient stress conditions via autophagy. Mol Med Rep. 13:1389–1394. 2016. View Article : Google Scholar : PubMed/NCBI
25	Tian R, Li Y and Yao X: PGRN suppresses inflammation and promotes autophagy in keratinocytes through the Wnt/β-catenin signaling pathway. Inflammation. 39:1387–1394. 2016. View Article : Google Scholar : PubMed/NCBI
26	McCord M, Mukouyama YS, Gilbert MR and Jackson S: Targeting WNT signaling for multifaceted glioblastoma therapy. Front Cell Neurosci. 11:3182017. View Article : Google Scholar : PubMed/NCBI